Inflammation is involved in the pathogenesis of AD, and lnc-ANRIL can regulate inflammation and cytokine expression through association with the NF-κB or other inflammatory pathways such as the BRCC3 signaling pathway. Here, CDKN2B-AS1 is linked to Alzheimer disease.